News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
FDA
Japan Approves First Generic Biotech Drug Somatropin From Novartis AG
June 26, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters - Japanese regulators approved a human growth hormone from Novartis AG, the first green light in Japan for a biosimilar or generic version of a biotech drug, the Swiss drugmaker said on Thursday.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
Asia
Novartis
MORE ON THIS TOPIC
diabetes
Lilly’s Foundayo posts ‘outstanding’ diabetes data, possibly easing FDA safety concerns
April 16, 2026
·
2 min read
·
Gabrielle Masson
Drug Development
Whitepaper: CDMOs at a Crossroads
April 15, 2026
·
1 min read
·
BioSpace Insights
Obesity
Lilly’s new obesity pill linked to ‘serious’ safety signals, FDA requests more data
April 15, 2026
·
2 min read
·
Tristan Manalac
Podcast
J&J targets $100B revenue, Replimune rebuffed again and a “Revolution” in pancreatic cancer
April 15, 2026
·
1 min read
·
Heather McKenzie
